InsideArbitrage Potential Deal Alert: Fulcrum Therapeutics (FULC) to Initiate Strategic Review
Fulcrum Therapeutics (FULC) announced the initiation of a comprehensive review of strategic alternatives to maximize stockholder value. Fulcrum will explore potential strategic alternatives, including a
Read More